phase readout
saveNCT07299955: A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Biocon Biologics UK PLC. Phase: PHASE1. Conditions: Healthy Male Participants
view source ↗
comments(0)
5-min edit window · permanent after that